Regulatory Notice: Applications described here may or may not be approved in your country. Please che
Elesta markets a proprietary device called EchoLaser for the non surgical, outpatient treatment of BPH, thyroid nodules and other diseases. EchoLaser is a medical device which combines ultrasound and laser technologies.
28/08/2025
Alle Molinette di Torino è stata realizzata una doppia rivoluzione in oncologia urologica: grazie alla terapia focale , i tumori prostatici localizzati possono essere rimossi con precisione millimetrica, preservando la funzionalità e limitando gli effetti collaterali.
Il vero salto di qualità? Il paziente, sveglio e operato in anestesia locale, può indossare un visore di realtà virtuale e “viaggiare” ai Caraibi, nella giungla amazzonica, nel cosmo o sott’acqua. Un’esperienza che non è mera distrazione, ma un vero ausilio psicologico per affrontare con più serenità la procedura.
Essere convinti di stare trascorrendo una vacanza ai Caraibi o di fare diving fra pesci multicolor, mentre invece si è su un lettino operatorio. Alle Molinette di Torino la pioneristica novità che cambia l'esperienza chirurgica del paziente con tumore alla prostata
29/07/2025
✨ A Verona, la tecnologia laser si fa internazionale.
Il 25 luglio all’AOUI Verona, il Prof. Alessandro Antonelli ha trattato con successo tre pazienti con ipertrofia prostatica benigna e uno con carcinoma prostatico utilizzando EchoLaser TPLA – Transperineal Laser Ablation.
Una procedura precisa, micro-invasiva e capace di preservare la funzione sessuale, osservata dal vivo anche da medici specialisti provenienti dal Regno Unito, interessati all’adozione della tecnologia nei loro ospedali.
Un grande grazie al Prof. Antonelli e alla sua équipe, a Elio Pachera per il prezioso supporto e a Rocamed, nostro licenziatario per l’urologia.
Prostata. Interventi innovativi con il laser a Borgo Trento per la terapia chirurgica dell'ipertrofia Prostatica benigna e del carcinoma
23/07/2025
✨ EchoLaser TPLA at the 12th Minimally Invasive Surgery in Aerospace Conference (China)
More than 400 experts from 28 provinces attended this key academic event.
We are proud of our partner Chenglai Pharmaceutical, a key participant for the third year in a row, and we warmly thank Dr. Paolo Polverino for his outstanding lecture on “EchoLaser TPLA: Technical Overview.”
Thanks to this collaboration, EchoLaser TPLA keeps being recognized as a reference technology in minimally invasive prostate laser ablation, pushing forward medical innovation worldwide.
14/07/2025
📢 A new prospective study published in Scientific Reports confirms it: patients prefer for !
🔬 by Elesta was the system used in this study of 204 patients conducted by Prof. Marcin Barczyński.
Here are the highlights:
A changing landscape of patients’ preferences for treatment of solitary and benign thyroid nodules (SBTN) form conventional surgery to other minimally invasive treatments (MITs) has been witnessed. The aim of this study was to evaluate indications, patients’ preferences and outcomes of conventio...
04/06/2025
🔵 International Collaboration: Prof. Ahmed Adel Abou-Talebs Clinical Tour in Italy
Over the past few days, we had the pleasure of welcoming Prof. Abou Taleb to Italy for a tour of top centers specializing in EchoLaser treatments.
📍 In Pisa, at Cisanello hospital, he met with Prof. Riccardo Bartoletti and Dr. Matteo Pacini. https://lnkd.in/ddMg8PDN
📍 In Bergamo, at Clinica San Francesco - Casa di Cura Privata, he was hosted by Dr. Gianluigi Patelli and Dr. Vincenzo Altieri. https://lnkd.in/dNrVnWfg
📍 Finally, in Florence, at Azienda Ospedaliero-Universitaria Careggi, he joined Dr. Francesco Sessa and Dr. Paolo Polverino, where he also received training on the system from Esaote for targeted prostate biopsies and focal therapy. https://lnkd.in/dMamC6c8
A heartfelt thank you to all the outstanding professionals involved for their warm welcome, expertise, and dedication. International clinical exchange is a key driver for advancing safe, effective, and innovative medical care. 🌍🤝
🙏 Special thanks also to Rocamed SAM, licensee of the EchoLaser technology, and to Mediclass, our distributor in Egypt, for their continued support in making this collaboration possible.
27/01/2025
🌟 Exciting News! 🌟
We are thrilled to announce our participation in the upcoming in this February.
This prestigious event represents a key opportunity to connect, exchange knowledge, and showcase our system.
Come and discover how Echolaser is redefining precision and treatment for . We look forward to engaging with experts, partners, and professionals passionate about advancing healthcare.
📅 Stay tuned for more updates as we approach the event!
16/09/2024
Elesta announces that the Chinese regulatory authority National Medical Products Administration (NMPA) has approved EchoLaser for use in prostatic diseases. This approval is a major achievement and represents a great opportunity for Elesta (distributed in China by Esaote). NMPA approval confirms once again the robustness of clinical data in urology, where EchoLaser has been demonstrated to be a safe and efficacious alternative to surgery for the treatment of Benign Prostatic Hyperplasia (BPH) and some forms of prostatic cancer.
23/07/2024
🚀 Exciting News in Medical Innovation! 🚀
We are thrilled to share that the Azienda Ospedaliero-Universitaria Pisana Ospedale Cisanello has recently introduced groundbreaking minimally invasive procedures for thyroid and prostate treatments, utilizing and . To further support this initiative, it has opened a dedicated office specifically for these laser treatments. These innovative techniques offer patients safer, faster, and more effective options with minimal recovery time. This marks a significant advancement in patient care, aligning with our commitment to improving health outcomes through cutting-edge technology.
We would like to share a special thanks to our user who made this possible:
Prof. Riccardo Bartoletti, Prof. Gabriele Materazzi with his equipe Dr. Piermarco Papini and Dr. Enrico Ambrosini, Dr.ssa Teresa Rago and Dr. Rocco Rago.
Al Centro di ricovero breve dell’Aoup
23/07/2024
🌟 Scopri : La Rivoluzione nella Terapia Mini-Invasiva per i 🌟
EchoLaser ModìLite è una tecnologia all'avanguardia che sta trasformando il panorama delle terapie . 🎯
🔬 : EchoLaser ModìLite combina l'energia laser e l'imaging ecografico in tempo reale per trattamenti precisi e sicuri. Questa soluzione offre risultati eccellenti con un impatto minimo sulla qualità della vita del paziente.
🏥 Vantaggi Clinici:
Estrema: Grazie al software dedicato Echolaser Smart Interface
Minimo Fastidio: La procedura mini-invasiva riduce il dolore e il tempo di recupero.
: Si adatta alle esigenze del paziente.
📈 Perché Scegliere EchoLaser ModìLite:
Operativa: Tempi di trattamento rapidi e riduzione delle degenze ospedaliere (hashtag
).
del Paziente Migliorata: Meno stress e un ritorno più veloce alle attività quotidiane.
Costi Ottimizzati: Riduzione delle spese sanitarie grazie a trattamenti ambulatoriali e tempi di recupero ridotti.
🔗 Unisciti alla Rivoluzione: Scopri come EchoLaser ModìLite può fare la differenza nel tuo ambito professionale. Insieme, possiamo offrire ai pazienti una cura migliore e più efficiente. 💪✨
🌟 Expanding Horizons in : Technology Event in Budapest 🌟
We're excited to share highlights from a recent event in , hosted by the forward-thinking team at Periodx Clinic, in collaboration with TOROMEDICAL and Elesta. This intimate, hands-on meeting aimed to elevate awareness of EchoLaser ModìLite technology for treating .
👩⚕️ Leading the Way 👨⚕️
The event brought together five distinguished participants from various regions and specializations across Hungary, all dedicated to the care of thyroid patients. The session was expertly guided by Dr. Viktor Lehoczki and Dr. Timea Varga. The main speaker, Dr. Daniela Sansone, an esteemed endocrinologist from Torino, provided a comprehensive presentation on the benefits and applications of EchoLaser ModìLite technology.
🎥 Live Demonstrations 🎥 During the event, two live cases were performed, showcasing the practical application of EchoLaser ModìLite technology. Dr. Sansone was on hand to offer her expert support, ensuring smooth and successful procedures.
🔍 Building Awareness 🔍
This event represents a crucial step towards enhancing the awareness and acceptance of innovative treatment options in Hungary. We are thrilled to witness growing interest in EchoLaser ModìLite among healthcare professionals dedicated to advancing thyroid care.
👏 Acknowledgments 👏
A heartfelt thank you to Dr Viktor Lehoczki and Dr. Timea Varga for organizing this impactful event, to Dr. Sansone for her invaluable insights and support, and to all the participants for their active engagement. Together, we are shaping the future of thyroid treatment in Hungary!
28/05/2024
I ᴠᴀɴᴛᴀɢɢɪ ᴅɪ ᴘᴇʀ ʟᴀ #ᴛᴇʀᴍᴏᴀʙʟᴀᴢɪᴏɴᴇ ᴅᴇɪ #ɴᴏᴅᴜʟɪ #ᴛɪʀᴏɪᴅᴇɪ sᴏɴᴏ ᴄʜɪᴀʀɪ ᴇᴅ ᴇᴠɪᴅᴇɴᴛɪ. Qᴜᴇsᴛᴏ ᴄɪ sᴘɪᴇɢᴀ ɪʟ Dʀ Fedele Antonio De Marino, ᴇsᴘᴇʀᴛᴏ ᴅᴇʟ sᴇᴛᴛᴏʀᴇ.
Lasciando la tua email puoi essere il primo a sapere quando Elesta - Beyond Laser pubblica notizie e promozioni. Il tuo indirizzo email non verrà utilizzato per nessun altro scopo e potrai annullare l'iscrizione in qualsiasi momento.
We develop innovative hi-tech therapeutic applications for interventional medicine. Our main product is EchoLaser: the first and unique integrated Laser-Ultrasound system that allows for the diagnosis and micro-invasive treatment of benign and malignant tumours. EchoLaser uses the laser radiation transmitted by independent sources (up to 4) through extremely thin optical fibres (0,3 mm) inserted percutaneously under a proprietary ultrasound guiding system (which includes a planning and simulation software). EchoLaser Therapy can induce a cytoreduction process on benign lesions (e.g.: BPH, thyroid nodules, etc.) or destroy cancerous tissue of malignant lesions (e.g.: metastatic lymph nodes, liver cancer, low-risk localized prostate and kidney cancer, etc.). No general anesthesia is generally required. Procedures can be performed in an outpatient regimen, with consequent faster recovery after treatment.
We want to play an important role in the new frontier of Precision Medicine, which is more than genomics and bespoke pharmacological treatment, but includes more accurate imaging and non surgical treatments (e.g. ablation).
The core EchoLaser Therapy treatments are:
ModìLite – neck lesions, such as benign thyroid nodules and metastatic lymph nodes.
SoracteLite – urinary system disorders like Benign Prostatic Hyperplasia (BPH) or low-risk localized prostate and kidney cancer. SoracteLite is the first and only laser treatment for BPH performed with a trans-perineal approach (reducing the complications of the traditional trans-urethral approach).
PBLite – treatment of primary and secondary malignant liver tumours through percutaneous insertion of optical fibres.
Elesta is developing other EchoLaser Therapy applications on soft tissues lesions such as the breast, pancreas and lungs, with the same aim that has driven the company since its foundation: protect the health of patients by providing innovative therapeutic solutions that are equally efficient,but less invasive than other existing mini-invasive treatments and traditional surgical treatments.
Information/images/intended uses mentioned/linked here aren't for USA, its territories & possessions
